-
-
-
-
-
-
-
Leading Independent Proxy Advisory Firm ISS Recommends Aptose Biosciences Shareholders Vote “FOR” Proposed Plan of Arrangement with Hanmi Pharmaceutical
-
-
-
-
-
-
-
Aptose Announces Proposed Public Offering of Common Shares
-
-
-
-
-
-
-
Aptose to Present New CG-806 Data at the 2018 ASH Annual Meeting
-
-
-
-
-
-
-
APTOSE Enters into US$20 Million Common Share Purchase Agreement with Aspire Capital Fund, LLC
-
-
-
-
-
-
1,171,480 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

